Researchers from the University of Massachusetts Amherst and the University of Massachusetts Chan Medical School have demonstrated in mice a new method to combat pancreatic cancer that relies on a nanoparticle drug-delivery system to activate an immune pathway, which usually recognizes viral infections in the body, in combination with tumor-targeting agents. "If we can trick the immune system into thinking that there is a viral-type infection, then we harness a very robust anti-tumor immune response to bring in for tumor immunotherapy," said Prabhani Atukorale, one of the scientists involved in this study.
An official website of the United States government.